SCHEMBL7360447

SCHEMBL7360447

N=C(N)NC(=O)c1cnn(-c2ccccc2)c1C1CC1.N=C(N)NC(=O)c1cnn(-c2ccccc2C(F)(F)F)c1C1CC1

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 3/20 0.53
NFE2L2 Q16236 3/20 0.53
SLC9A1 P19634 2/20 0.52
SLC9A2 Q9UBY0 2/20 0.52
ALDH1A1 P00352 2/20 0.44
KDM4E B2RXH2 1/20 0.44
POLB P06746 3/20 0.43
HTT P42858 1/20 0.43
KMT2A Q03164 1/20 0.43
MAPT P10636 5/20 0.43
LMNA P02545 3/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HSD11B1 P28845 1/20 0.41
TDP1 Q9NUW8 1/20 0.40
THRB P10828 1/20 0.40
TP53 P04637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4450205 0.95 SLC9A1 (0.48) KEAP1NFE2L2SLC9A1SLC9A2ALDH1A1
Hydrochloric Acid SCHEMBL6314755 0.94 SLC9A1 (0.48) KEAP1NFE2L2SLC9A1SLC9A2ALDH1A1
Hydrochloric Acid SCHEMBL6321489 0.93 SLC9A1 (0.47) KEAP1NFE2L2SLC9A1SLC9A2ALDH1A1
SCHEMBL4452217 0.88 KEAP1 (0.67) KEAP1NFE2L2SLC9A1SLC9A2ALDH1A1
Hydrochloric Acid SCHEMBL6312407 0.87 KEAP1 (0.66) KEAP1NFE2L2SLC9A1SLC9A2ALDH1A1
SCHEMBL4452076 0.82 TP53 (0.47) SLC9A1SLC9A2POLBMAPTLMNA
SCHEMBL4452480 0.82 SMN1; SMN2 (0.40) KEAP1NFE2L2SLC9A1SLC9A2ALDH1A1
Hydrochloric Acid SCHEMBL6311494 0.82 TP53 (0.46) SLC9A1SLC9A2POLBMAPTLMNA
SCHEMBL4446803 0.81 SLC9A1 (0.51) KEAP1NFE2L2SLC9A1SLC9A2MAPT
SCHEMBL6482935 0.81 TP53 (0.43) SLC9A1SLC9A2POLBKMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6423705-B1 FOR ISCHEMIA BY ADMINISTERING AN NHE-1 INHIBITOR AND A SECOND COMPOUND SELECTED FROM COMPLEMENT MODULATOR, METABOLIC MODULATOR, ANTIAPOPTOTIC AGENT, NITRIC OXIDE SYNTHASE-RELATED AGENT, AND AN ENZYME/PROTEIN MODULATOR PFIZER INC. 2002-07-23 US claimed